Innovation Pharmaceuticals Inc. financial data

Symbol
IPIX on OTC
Industry
Pharmaceutical Preparations
Location
301 Edgewater Place, Suite 100, Wakefield, MA
Fiscal year end
June 30
Former names
Cellceutix CORP (to 5/9/2017), EconoShare, Inc. (to 5/15/2008)
Latest financial report
10-Q - Q3 2023 - Nov 20, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 35.7 % -73.7%
Debt-to-equity 243 % +116%
Return On Equity -116 % -28.9%
Return On Assets -34 % +20.2%
Operating Margin -13.2K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 514M shares +5.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 874K USD -74.3%
General and Administrative Expense 592K USD -55.5%
Operating Income (Loss) -2.56M USD +46.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.62M USD +44.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 864K USD -70.9%
Assets, Current 940K USD -69.6%
Assets 6.67M USD -28.6%
Accounts Payable, Current 3.02M USD +3.57%
Employee-related Liabilities, Current 1.59M USD -3.82%
Accrued Liabilities, Current 192K USD +113%
Liabilities, Current 5.05M USD -1.62%
Operating Lease, Liability, Noncurrent 0 USD
Other Liabilities, Noncurrent 457K USD -41.9%
Liabilities 5.51M USD -6.96%
Retained Earnings (Accumulated Deficit) -126M USD -2.12%
Stockholders' Equity Attributable to Parent 1.16M USD -66%
Liabilities and Equity 6.67M USD -28.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -677K USD +14.4%
Net Cash Provided by (Used in) Financing Activities 25K USD
Net Cash Provided by (Used in) Investing Activities -2K USD +50%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 864K USD -70.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 39.4M USD +1.45%
Deferred Tax Assets, Gross 39.4M USD +1.45%
Operating Lease, Liability 55K USD -78.2%
Operating Lease, Liability, Current 0 USD -100%
Operating Lease, Weighted Average Discount Rate, Percent 0.18 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 29.9M USD +3.38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 55K USD -6.78%
Additional Paid in Capital 130M USD +0.28%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 374K USD -1.58%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 32K USD -95.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%